Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.57B |
| 2 |
Tesla
TSLA
|
+$1.06B |
| 3 |
Amazon
AMZN
|
+$597M |
| 4 |
Qualcomm
QCOM
|
+$374M |
| 5 |
AbbVie
ABBV
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$561M |
| 3 |
UnitedHealth
UNH
|
+$353M |
| 4 |
Meta Platforms (Facebook)
META
|
+$345M |
| 5 |
Starbucks
SBUX
|
+$340M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.63% |
| 2 | Technology | 13.19% |
| 3 | Consumer Discretionary | 10.53% |
| 4 | Financials | 8.74% |
| 5 | Communication Services | 7.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Capital One
COF
$137B
| $14.3M | 0.01% |
139,199
+130,599
| +1,519% | +$12.6M |
|
1202
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.7B
| $14.3M | 0.01% |
156,650
+46,700
| +42% | +$4.27M |
|
|
CPL
1203
DELISTED
CPFL Energia S.A.
CPL
| $14.3M | 0.01% |
830,611
-282,300
| -25% | -$4.48M |
|
1204
iShares 0-1 Year Treasury Bond ETF
SHV
$20.6B
| $14.3M | 0.01% |
129,626
+39,126
| +43% | +$4.33M |
|
1205
Lowe's Companies
LOW
$122B
| $14.3M | 0.01% |
119,000
-1,230,400
| -91% | -$141M |
|
1206
Cenovus Energy
CVE
$56.4B
| $14.2M | 0.01% |
1,400,832
-694,768
| -33% | -$6.3M |
|
1207
Agilysys
AGYS
$3.03B
| $14.2M | 0.01% |
559,752
+3,352
| +0.6% | +$84.8K |
|
|
AY
1208
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
| $14.2M | 0.01% |
538,920
+311,980
| +137% | +$7.8M |
|
|
GDEN
1209
DELISTED
Golden Entertainment
GDEN
| $14.2M | 0.01% |
739,146
+328,285
| +80% | +$5.37M |
|
1210
Evolution Petroleum
EPM
$134M
| $14.2M | 0.01% |
2,594,972
+167,840
| +7% | +$923K |
|
|
ARCH
1211
DELISTED
Arch Resources, Inc.
ARCH
| $14.2M | 0.01% |
197,800
+2,700
| +1% | +$207K |
|
|
SAFE
1212
Safehold
SAFE
$1.1B
| $14.1M | 0.01% |
200,242
-95,283
| -32% | -$6.03M |
|
1213
State Street Blackstone Senior Loan ETF
SRLN
$5.38B
| $14.1M | 0.01% |
303,586
+124,504
| +70% | +$5.74M |
|
|
RVI
1214
DELISTED
Retail Value Inc. Common Shares
RVI
| $14.1M | 0.01% |
4,174,108
+415,654
| +11% | +$1.39M |
|
1215
First Trust Preferred Securities and Income ETF
FPE
$6.34B
| $14.1M | 0.01% |
700,799
+247,028
| +54% | +$4.92M |
|
|
BFIN
1216
DELISTED
BankFinancial
BFIN
| $14.1M | 0.01% |
1,074,566
+14,366
| +1% | +$187K |
|
1217
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
$4.81B
| $14.1M | 0.01% |
521,697
+276,624
| +113% | +$7.41M |
|
1218
Quest Diagnostics
DGX
$26.2B
| $14M | 0.01% |
131,300
+35,000
| +36% | +$3.65M |
|
1219
Trade Desk
TTD
$6.84B
| $14M | 0.01% |
539,000
-416,000
| -44% | -$9.36M |
|
1220
York Water
YORW
$528M
| $14M | 0.01% |
303,436
-2,800
| -0.9% | -$123K |
|
1221
WisdomTree
WT
$3.44B
| $14M | 0.01% |
2,889,089
+609,287
| +27% | +$3.02M |
|
1222
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
| $14M | 0.01% |
122,000
+119,200
| +4,257% | +$13.5M |
|
|
MCBC
1223
DELISTED
Macatawa Bank Corp
MCBC
| $14M | 0.01% |
1,253,662
+96,800
| +8% | +$1.03M |
|
1224
Foster
FSTR
$405M
| $13.9M | 0.01% |
719,199
+7,099
| +1% | +$138K |
|
1225
Fair Isaac
FICO
$24B
| $13.9M | 0.01% |
37,150
+35,750
| +2,554% | +$12M |
|
Similar funds
Jim Simons's Q4 2019 Portfolio in Review
As of Q4 2019, Jim Simons held 3,913 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jim Simons's Q4 2019 filing shows 518 new, 1,836 increased, 1,085 reduced and 443 closed positions. Its largest new stake was Amazon: 6,745,100 shares worth $623M. The largest sale was Celgene Corp, an estimated $1.54B.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2019 buy was Amazon: 6,745,100 shares worth $623M.
- Jim Simons added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.57B increase.
- Jim Simons's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $561M.
- Jim Simons fully exited Celgene Corp in Q4 2019, selling an estimated $1.54B.
- Jim Simons's ten largest holdings make up 13% of its $130B portfolio in Q4 2019.
- Jim Simons opened 518 new positions and closed 443 in Q4 2019.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.